GHK-CU – 100mg

GHK-Cu is a copper-binding tripeptide complex formed from glycyl-L-histidyl-L-lysine (GHK) and copper. It is also commonly referred to as Copper Tripeptide-1 or GHK Copper.

GHK has a strong affinity for copper ions, making the resulting complex useful in laboratory research examining peptide–metal interactions and copper-associated cellular processes.

GHK-Cu has also been investigated in experimental models involving fibroblast activity, extracellular-matrix regulation and cellular signalling. Pronoia supplies the material in a 100mg research format with batch traceability and supporting documentation available.

Product: GHK-Cu

Alternative names: Copper Tripeptide-1 / GHK Copper

Specification: 100mg

Material class: Tripeptide–copper complex

Form: Solid / lyophilised material (batch dependent)

Appearance: Blue to blue-green

Minimum purity standard: ≥98%

Batch traceability: Maintained

SKU: PB-GHKCU-100

Pronoia maintains batch traceability for GHK-Cu and retains supporting analytical documentation for the supplied research material.

Independent analytical testing supports product quality assessment, with batch-specific documentation used to record identity, purity and consistency.

Because GHK-Cu contains a coordinated copper ion and may show some visual variation between batches, appearance alone should not be used to assess analytical quality. Batch-specific results and the corresponding Certificate of Analysis should be treated as the authoritative reference.

Certificate of Analysis (COA) and Safety Data Sheet (SDS) documentation are available to support laboratory records and material assessment.

GHK-Cu has been investigated in experimental research involving copper-dependent peptide biology, fibroblast activity and extracellular-matrix regulation.

Relevant research areas include:

• Peptide–copper binding and metal coordination
• Fibroblast signalling and cellular activity
• Collagen and extracellular-matrix biology
• Matrix-remodelling mechanisms
• Cellular signalling and regulatory pathways
• Structure–function relationships of copper-binding peptides

Experimental studies have reported effects of GHK-Cu on collagen synthesis and matrix-remodelling processes in fibroblast models, while other work has examined the importance of the copper component itself in these biological responses.

These findings describe controlled experimental research and should not be interpreted as evidence of an established therapeutic or cosmetic effect from the material supplied by Pronoia.

GHK-Cu should be stored and handled according to the conditions specified by Pronoia and the applicable batch documentation.

The material should be protected from unnecessary heat, moisture and repeated environmental exposure, with appropriate laboratory procedures used during preparation and handling.

Visual colour differences can occur between supplied materials. Batch documentation and analytical results should therefore be used when assessing product specification rather than colour alone.

Where batch-specific storage instructions are supplied, those instructions should take precedence.

GHK-Cu is supplied through Pronoia’s tracked UK delivery service using its established research-product fulfilment process.

Batch traceability is maintained, with Certificate of Analysis (COA) and Safety Data Sheet (SDS) documentation available to support laboratory records and material assessment.

Current dispatch availability and applicable delivery conditions are displayed directly on the product page and remain subject to Pronoia’s delivery terms.

GHK-Cu supplied by Pronoia Bio is intended strictly for controlled laboratory research and experimental use.

It is not supplied for human or veterinary use and should not be treated as a medicine, cosmetic treatment or consumer healthcare product.

Purchasers are responsible for ensuring that the material is used appropriately within their research environment and in accordance with applicable requirements.